PFWA
BBIO icon

Paces Ferry Wealth Advisors’s BridgeBio Pharma BBIO Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25
Closed -$1K – 215
2020
Q3 		$1K Buy
+25
New +$787 ﹤0.01% 771

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Paces Ferry Wealth Advisors's BBIO Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of BridgeBio Pharma (BBIO) in Q4 2020, closing a stake of 25 shares — an estimated $1K sold.

Paces Ferry Wealth Advisors first reported a position in BBIO in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 161 funds tracked by Wall St. Rank hold BBIO as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining BridgeBio Pharma position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 25 BridgeBio Pharma shares in Q4 2020, an estimated $1K.
  • Paces Ferry Wealth Advisors first reported a position in BridgeBio Pharma in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's BridgeBio Pharma position peaked at $1K in Q3 2020.
  • 161 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.